Atlas Trials

Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab

Clinical trial NCT01752855 · COMPLETED

Trial details

NCT number
NCT01752855
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2012-12-01
Primary completion
2013-10-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.